|
Dramatic advances in diabetes treatment and
prevention have occurred over the past decade. Landmark clinical trials
such as the Diabetes Control and Complications Trial (DCCT) and the United
Kingdom Prospective Diabetes Study (UKPDS) have demonstrated the importance
of intensive blood glucose and blood pressure control. More recently,
the Diabetes Prevention Program (DPP) showed that lifestyle intervention,
addressing weight loss and maintenance and increased exercise, as well
as treatment with the drug metformin, delay or prevent the onset of type
2 diabetes in people at high risk for developing the disease.
Translational research
aims to determine what can improve outcomes in diverse, real-world populations
and how to achieve these goals in a practical way that positively affects
public health. This conference is organized by the NIDDK in collaboration
with the NIH Office of Behavioral and Social Sciences Research and the
CDC. It will bring together investigators, health care providers, NIH
representatives, and payers to discuss barriers to translation, translational
research, translational interventions, community-based approaches, and
public health efforts. A primary conference objective is to foster ideas
to improve treatment for individuals with or at risk for diabetes through
implementation of known and newly emerging prevention and treatment strategies.
|
||
National Institute of Diabetes & Digestive & Kidney Diseases |